Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

PH dependence of a GPR4 selective antagonist hampers its therapeutic potential

ABSTRACT: pH dependence of a GPR4 selective antagonist hampers its therapeutic potential

PROVIDER: PRJNA937172 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR23565533_1.fastq.gz	Fastqsanger.gz
	SRR23565533_2.fastq.gz	Fastqsanger.gz
	SRR23565534_1.fastq.gz	Fastqsanger.gz
	SRR23565534_2.fastq.gz	Fastqsanger.gz
	SRR23565535_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 90

Similar Datasets

pH dependence of a GPR4 selective antagonist hampers its therapeutic potential

Project description:Inflammatory bowel disease (IBD) is characterized by chronic mucosal inflammation of the gastrointestinal tract and is associated with extracellular acidification of mucosal tissue. Several extracellular pH-sensing receptors, including G protein-coupled receptor 4 (GPR4), play an important role in the regulation of inflammatory and immune responses and GPR4 deficiency has been shown to be protective in IBD animal models. To confirm the therapeutic potential of GPR4 antagonism in IBD, we tested Compound 13, a selective GPR4 antagonist, in the IL10-/- mouse model of colitis. Despite reasonable bioavailability, Compound 13 treatment did not improve colitis in this model and there were no signs of target engagement. Interestingly, Compound 13 behaved as an “orthosteric” antagonist, i.e., its potency was pH-dependent and mostly inactive at pH levels lower than 6.8 with preferential binding to the inactive conformation of GPR4. Mutagenesis studies confirmed Compound 13 likely binds to the conserved orthosteric binding site in G protein-coupled receptors, where a histidine sits in GPR4 likely preventing Compound 13 binding when protonated in acidic conditions. While the exact mucosal pH in the human disease and relevant IBD mice models is unknown, it is well established that the degree of acidosis is positively correlated with the degree of inflammation, suggesting Compound 13 is not an ideal tool to study the role of GPR4 in moderate-to-severe inflammatory conditions.

2024-01-03 | GSE225694 | GEO

Selective Mediator dependence of cell-type-specifying transcription

Project description:Selective Mediator dependence of cell-type-specifying transcription

| PRJNA579913 | ENA

Selective Mediator-dependence of cell type-specifying transcription [HiChIP]

Project description:Selective Mediator-dependence of cell type-specifying transcription [HiChIP]

| PRJNA579928 | ENA

Selective Mediator-dependence of cell type-specifying transcription [PRO-seq]

Project description:Selective Mediator-dependence of cell type-specifying transcription [PRO-seq]

| PRJNA579916 | ENA

Selective Mediator-dependence of cell type-specifying transcription [Quant-Seq]

Project description:Selective Mediator-dependence of cell type-specifying transcription [Quant-Seq]

| PRJNA579917 | ENA

Selective Mediator-dependence of cell type-specifying transcription [4C-seq]

Project description:Selective Mediator-dependence of cell type-specifying transcription [4C-seq]

| PRJNA579914 | ENA

Selective Mediator-dependence of cell type-specifying transcription [TT-seq]

Project description:Selective Mediator-dependence of cell type-specifying transcription [TT-seq]

| PRJNA579915 | ENA

Selective Mediator-dependence of cell type-specifying transcription [ChIP-seq]

Project description:Selective Mediator-dependence of cell type-specifying transcription [ChIP-seq]

| PRJNA579927 | ENA

IL-2 is inactivated by the acidic pH environment of tumors enabling engineering of a pH-selective mutein (scRNA-Seq)

Project description:Cytokines interact with their receptors in the extracellular space to control immune responses. How the physicochemical properties of the extracellular space influence cytokine signaling is incompletely elucidated. Here, we show that the activity of interleukin (IL)-2, a critical cytokine in T cell immunity, is profoundly affected by pH, limiting IL-2 signaling within the acidic environment of tumors. Generation of lactic acid by tumors limits STAT5 activation, effector differentiation and anti-tumor immunity by CD8+ T cells and renders high-dose IL-2 therapy poorly effective. Directed evolution enabled selection of a pH-selective IL-2 mutein (Switch-2). Switch-2 binds the IL-2 receptor subunit IL-2Ra with higher affinity, triggers STAT5 activation and drives CD8+ T cell effector function more potently at acidic pH than at neutral pH. Consequently, high-dose Switch-2 therapy induces potent immune activation and tumor rejection with reduced on-target toxicity in normal tissues. Finally, we find that sensitivity to pH is a generalizable property of a diverse range of cytokines with broad relevance to immunity and immunotherapy in healthy and diseased tissues.

2022-12-02 | GSE213440 | GEO

IL-2 is inactivated by the acidic pH environment of tumors enabling engineering of a pH-selective mutein (RNA-Seq)

2022-12-02 | GSE213439 | GEO